1. Home
  2. SCPH vs VSTA Comparison

SCPH vs VSTA Comparison

Compare SCPH & VSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • VSTA
  • Stock Information
  • Founded
  • SCPH 2013
  • VSTA 1966
  • Country
  • SCPH United States
  • VSTA Brazil
  • Employees
  • SCPH N/A
  • VSTA N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • VSTA Other Consumer Services
  • Sector
  • SCPH Health Care
  • VSTA Real Estate
  • Exchange
  • SCPH Nasdaq
  • VSTA Nasdaq
  • Market Cap
  • SCPH 299.0M
  • VSTA 332.9M
  • IPO Year
  • SCPH 2017
  • VSTA 2020
  • Fundamental
  • Price
  • SCPH $5.63
  • VSTA $4.57
  • Analyst Decision
  • SCPH Buy
  • VSTA
  • Analyst Count
  • SCPH 3
  • VSTA 0
  • Target Price
  • SCPH $12.00
  • VSTA N/A
  • AVG Volume (30 Days)
  • SCPH 2.3M
  • VSTA 25.0K
  • Earning Date
  • SCPH 11-12-2025
  • VSTA 11-06-2025
  • Dividend Yield
  • SCPH N/A
  • VSTA N/A
  • EPS Growth
  • SCPH N/A
  • VSTA N/A
  • EPS
  • SCPH N/A
  • VSTA 1.09
  • Revenue
  • SCPH $49,969,000.00
  • VSTA $313,466,268.00
  • Revenue This Year
  • SCPH $108.95
  • VSTA $12.29
  • Revenue Next Year
  • SCPH $78.30
  • VSTA $11.91
  • P/E Ratio
  • SCPH N/A
  • VSTA $4.13
  • Revenue Growth
  • SCPH 107.79
  • VSTA 8.99
  • 52 Week Low
  • SCPH $1.94
  • VSTA $1.60
  • 52 Week High
  • SCPH $6.28
  • VSTA $5.49
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 64.37
  • VSTA 67.17
  • Support Level
  • SCPH $4.33
  • VSTA $4.44
  • Resistance Level
  • SCPH $5.62
  • VSTA $4.68
  • Average True Range (ATR)
  • SCPH 0.05
  • VSTA 0.23
  • MACD
  • SCPH 0.01
  • VSTA 0.02
  • Stochastic Oscillator
  • SCPH 93.75
  • VSTA 79.00

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

Share on Social Networks: